Masimo Corporation Company Profile

10:13 EST 13th December 2018 | BioPortfolio

Founded in 1989, Masimo Corporation, the innovator of motion and low perfusion tolerant pulse oximetry, is a privately held medical technology company that develops, licenses and markets advanced medical signal processing technologies and products for the noninvasive monitoring of patient vital signs.
Masimo Signal Extraction Technology pulse oximetry, Masimo SET®, represents a fundamental departure from conventional pulse oximetry technologies. Over 60 independent published studies have demonstrated that Masimo SET substantially overcomes the limitations of conventional pulse oximeters in accurately measuring arterial blood oxygen saturation levels and pulse rates in the presence of patient movement and low perfusion. To date, Masimo has licensed its Signal Extraction pulse oximetry technology to over 35 international patient monitoring systems providers, which make up over 60% of the world's pulse oximeter shipments. We invite you to learn more about the products, people, and services that have brought us to where we are today.


40 Parker
United States of America


Phone: 1 (949) 297-7000
Fax: 1 949 297-7499

News Articles [123 Associated News Articles listed on BioPortfolio]

New Study Investigates the Utility of Home Monitoring Using Masimo SET® Pulse Oximetry to ...

Media Contact:MasimoEvan Lamb,

Researchers investigate ability of Masimo ORi to reduce time ICU patients experience hyperoxemia

Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigat...

FDA approves Masimo RD sensors with enhanced accuracy for SET pulse oximetry

The RD SET sensors with Masimo measure-through motion and low perfusion SET pulse oximetry have secured FDA clearance with improved SpO2 accuracy specifications for all patients above 3kg. The post F...

Masimo's enhanced RD SET sensors obtain FDA clearance

The FDA has granted Masimo 510(k) clearance for its RD SET sensors that come with measure-through motion and low perfusion SE -More- 

Study investigates use of Masimo’s SET Pulse Oximetry to screen Down Syndrome children

The home monitoring was conducted using Masimo’s SET Measure through motion and low perfusion pulse oximetry. As part of the study, 161 children with DS aged between 0.5 The post Study investigates...

Masimo to Present at Stifel 2018 Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Stifel 2018 Healthcare Conference at the Palace Hotel in New York on Wednesday, Nov...

Masimo to Present at Morgan Stanley 16th Annual Global Healthcare Conference

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Morgan Stanley 16th Annual Global Healthcare Conference at the Grand Hyatt Hotel in...

New study evaluates ability of Masimo's ORi to detect decreasing blood oxygenation during OLV

Researchers from Iwate Medical University of Japan have conducted a study to evaluate the ability of Masimo's ORi (Oxygen Reserve Index) in providing early detection of blood oxygenation decrease duri...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

The plethysmographic variability index does not predict fluid responsiveness estimated by esophageal Doppler during kidney transplantation: A controlled study.

Research is ongoing to find a noninvasive method of monitoring, which can predict fluid responsiveness in patients undergoing kidney transplantation.To compare the responses to fluid challenges with t...

Clinical Trials [29 Associated Clinical Trials listed on BioPortfolio]

Masimo Radical Pulse Co-oximeter in Intraoperative Blood Transfusion Practice During Obestatric Procedure

The principle aim of this study is to detect the accurracy of Masimo Radical-7¿ Pulse CO-Oximeter in relation to laboratory hemoglobin and estimated blood loss in intraoperative blood tra...

ORI: Utility as Early Warning for Desaturation in Morbidly Obese Patients

This is a prospective, observational, clinical study designed to evaluate the clinical utility of the ORI as an early warning for arterial hemoglobin desaturation during the induction of g...

Plethysmography Variability Index Monitoring for Parturients With Antepartum Hemorrhage

The purpose of this study is to evaluate the use of continuous noninvasive intraoperative plethesmography variability index in conjunction with Hemoglobin levels monitoring using Masimo Ra...

Sedline 4 Channel Electroencephalogram (EEG) Monitoring During Suppression of Unilateral Hemispheric Function (Wada Test

Masimo Sedline brain function monitors are sensors (stickers) placed on a the forehead to monitor levels of "sedation" based on a bilateral 4-channel electroencephalogram (EEG). The purpos...

PVI Based Intraoperative Fluid Management in Head and Neck Free Flap Reconstructive Surgeries

Intraoperative fluid given according to BMI in group B and according to pulse oximeter- derived pleth variability index(MASIMO RAINBOW PULSE CO OXIMETRY) in group G. Comparison of haemodyn...

Companies [184 Associated Companies listed on BioPortfolio]


Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care--helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and...

Masimo Corporation

Founded in 1989, Masimo Corporation, the innovator of motion and low perfusion tolerant pulse oximetry, is a privately held medical technology company that develops, licenses and markets advanced medi...

Masimo Corp.

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Masimo Corporation" on BioPortfolio

We have published hundreds of Masimo Corporation news stories on BioPortfolio along with dozens of Masimo Corporation Clinical Trials and PubMed Articles about Masimo Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Masimo Corporation Companies in our database. You can also find out about relevant Masimo Corporation Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record